María-Victoria Mateos

Professor María-Victoria Mateos is a Consultant Physician in the Hematology Department at the University Hospital of Salamanca, Salamanca, ES, and an Associate Professor of Medicine. She is also the Director of the Myeloma Program and coordinates the Clinical Trials Unit at the University Hospital of Salamanca.  

Professor Mateos serves as coordinator of the Spanish Myeloma Group (GEM), with direct involvement in the design and development of clinical trials. She has coordinated many clinical trials, especially in the smoldering myeloma setting, which have profoundly influenced current treatment options. 

Professor Mateos is a member of the International Myeloma Working Group, International Myeloma Society (IMS), European School of Haematology (ESH), and American Society of Hematology (ASH). She served on the ASH Scientific Committee on Plasma Cell Diseases between 2015 and 2019 and on the European Hematology Association (EHA) Scientific Program Committee and Advisory Board from 2013 to 2020, acting as chair of the Scientific Program Committee in 2019. In addition, she is a member of the Society of Hematologic Oncology (SOHO) Steering Committee, a member of the IMS board, a member of the ESH Scientific Committee, and was a Councilor on the EHA Board from 2015 for a 4-year mandate. 

Professor Mateos has authored over 400 peer-reviewed publications and frequently presents her work nationally and internationally. She received the Brian Durie Award in 2019 and more recently achieved the Bart Barlogie Clinical Investigator Award, both of which recognize excellence in myeloma research.